Cargando…
Neuron-specific enolase in cerebrospinal fluid as a biomarker of brain damage in infants with hypoxic-ischemic encephalopathy
Autores principales: | Garcia-Alix, Alfredo, Arnaez, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463987/ https://www.ncbi.nlm.nih.gov/pubmed/34269199 http://dx.doi.org/10.4103/1673-5374.317972 |
Ejemplares similares
-
Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia
por: León-Lozano, Marisol-Zulema, et al.
Publicado: (2020) -
Potential use of lactate for the treatment of neonatal hypoxic-ischemic encephalopathy
por: Tassinari, Isadora D'Ávila, et al.
Publicado: (2021) -
Serum and Cerebrospinal Fluid Neuron-Specific Enolase for Diagnosis of Tuberculous Meningitis
por: Song, Tae-Jin, et al.
Publicado: (2012) -
Peptidome analysis of cerebrospinal fluid in neonates with hypoxic-ischemic brain damage
por: Hou, Xuewen, et al.
Publicado: (2020) -
Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
por: Douglas-Escobar, Martha, et al.
Publicado: (2012)